Added 1 year ago Drug news

Phase II trial of WT1 cancer vaccine doubles progression-free survival in malignant pleural mesothelioma- SELLAS Life Sciences

SELLAS Life Sciences Group announced that results from a Phase II trial of the Company's WT1 cancer vaccine in patients...

Added 1 year ago Drug news

Tremelimumab fails in Phase IIb trial for unresectable malignant mesothelioma- AstraZeneca

AstraZeneca and MedImmune, its global biologics research and development arm, announced that DETERMINE, the Phase IIb clinical trial of 10...

Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over

This guideline covers assessing and managing cancers of the upper aerodigestive tract in young people (aged 16 and over) and...

Added 1 year ago

• 2
  Likes

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Malignant pleural mesothelioma (MPM) is considered to be a relatively rare tumour, although incidence has increased during the last ten...

Added 2 years ago

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.

Malignant pleural mesothelioma is an aggressive cancer with poor prognosis, linked to occupational asbestos exposure. Vascular endothelial growth factor is a key mitogen for malignant pleural mesothelioma cells, therefore targeting...

Added 9 months ago

Global cancer statistics, 2012

Cancer constitutes an enormous burden on society in more and less economically developed countries alike.

Added 2 years ago

Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: The outcome of incomplete resections

Background: The type of surgery (radical pleurectomy (RP) vs. extrapleural pneumonectomy (EPP)) remains controversial for malignant pleural mesothelioma (MPM). Macroscopic...

Added 4 years ago